- Poster presentation
- Open Access
Optimization of gadofosveset intravenous injection scheme for coronary MRA: the pharmacokinetics approach
© Ahlman et al.; licensee BioMed Central Ltd. 2014
- Published: 16 January 2014
- Double Dose
- Slow Infusion
- Injection Parameter
- Optimal Steady State
- Dual Injection
Towards motion-free diagnostic coronary MRA, lengthy (10-15 min) sequences are required. Conventional GBCAs are unable to sustain steady-state intravascular concentrations long enough to maintain low enough T1 signal for good signal/contrast to noise levels. Arterial and venous mixing of contrast takes time that cannot be used for scanning using our free-breathing self-navigated motion-corrected MRA sequence[2, 3]. Gadofosveset has a high intravascular residence time and high relaxivity compared to other GBCAs; therefore, we study various injection parameters to accomplish a low T1 time for the longest period of time, as well as a quick equilibrium time with this agent using a dual bolus/slow infusion injection technique.
X Normal volunteers without a history of cardiac disease and under the age of 40 were selected for scanning on a Siemens Verio 3T scanner following IRB approved informed consent. Gadofosveset was injected with a dual injection protocol using a Spectris Solaris EP (MEDRAD Inc, Pittsburgh, PA, USA) MR injector using a 70%/%30 and a 60%/40% bolus/slow injection technique. Other variables for injection included the the insertion of a 20-30 second pause between bolus and slow infusion, 1.5 mL/s vs. 3.0 mL/s bolus phase, and single (0.03 mmol/kg) vs double dose (0.06 mmol/kg). Breath-hold, 4-chamber view, single-slice Modified Look-Locker Inversion Recovery (MOLLI) sequences with 11 heart beats were used to measure absolute T1 time in the lumen of the left ventricle using QMass MR ver 7.2 (Medis, Raleigh, NC, USA). Unpaired Mann-Whitney t-testing was used to compare variables for statistical significant difference in medians (p < 0.05).
Using Gadofosveset as a GBCA for self-navigated motion-corrected MRA, we demonstrated how various contrast injection parameters can be used for optimal steady state intravascular concentration for the longest T1 relaxivity. Paradoxically, a double dose protocol increases the time to equilibrium, which does not currently have a clear scientific rationale. Multivariate models are pending, which may elicidate these findings. The length of equilibrium is lengthened by using a protocol that has more contrast in the slow
This study is funded by the NIH intramural program.
- Alex Frydrychowicz M, Russe MF, Jelena Bock M: Comparison of Gadofosveset Trisodium and Gadobenate Dimeglumine During Time-Resolved Thoracic MR Angiography at 3T. 2010, 17 (11): 1394-1400.Google Scholar
- Pang J, Bhat H, Sharif B, Fan Z: Self-guided retrospective motion correction (SEGMO) for free-breathing whole-heart coronary MRA with 100% acquisition efficiency. Journal of Cardiovascular Magnetic Resonance. 2012, 14 (Suppl 1): M10-10.1186/1532-429X-14-S1-M10.PubMed CentralView ArticleGoogle Scholar
- Bhat H, Ge L, Nielles-Vallespin S, Zuehlsdorff S, Li D: 3D radial sampling and 3D affine transform-based respiratory motion correction technique for free-breathing whole-heart coronary MRA with 100% imaging efficiency. Magnetic Resonance in Medicine. 2011, 65 (5): 1269-1277. 10.1002/mrm.22717.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.